Theragen Financial Statements From 2010 to 2024

066700 Stock  KRW 3,205  70.00  2.23%   
Theragen Etex financial statements provide useful quarterly and yearly information to potential Theragen Etex CoLtd investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Theragen Etex financial statements helps investors assess Theragen Etex's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Theragen Etex's valuation are summarized below:
Theragen Etex CoLtd does not presently have any fundamental trend indicators for analysis.
Check Theragen Etex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Theragen Etex's main balance sheet or income statement drivers, such as , as well as many indicators such as . Theragen financial statements analysis is a perfect complement when working with Theragen Etex Valuation or Volatility modules.
  
This module can also supplement various Theragen Etex Technical models . Check out the analysis of Theragen Etex Correlation against competitors.

Theragen Etex CoLtd Company Current Valuation Analysis

Theragen Etex's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Theragen Etex Current Valuation

    
  298.28 B  
Most of Theragen Etex's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Theragen Etex CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Theragen Etex CoLtd has a Current Valuation of 298.28 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.

Theragen Etex CoLtd Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Theragen Etex's current stock value. Our valuation model uses many indicators to compare Theragen Etex value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Theragen Etex competition to find correlations between indicators driving Theragen Etex's intrinsic value. More Info.
Theragen Etex CoLtd is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Theragen Etex by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Theragen Etex's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Theragen Etex Financial Statements

Theragen Etex stakeholders use historical fundamental indicators, such as Theragen Etex's revenue or net income, to determine how well the company is positioned to perform in the future. Although Theragen Etex investors may analyze each financial statement separately, they are all interrelated. For example, changes in Theragen Etex's assets and liabilities are reflected in the revenues and expenses on Theragen Etex's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Theragen Etex CoLtd. Please read more on our technical analysis and fundamental analysis pages.
,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products. ,Ltd. was founded in 1987 and is headquartered in Seoul, South Korea. THERAGEN ETEX is traded on Korean Securities Dealers Automated Quotations in South Korea.

Pair Trading with Theragen Etex

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Theragen Etex position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theragen Etex will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Theragen Etex could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Theragen Etex when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Theragen Etex - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Theragen Etex CoLtd to buy it.
The correlation of Theragen Etex is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Theragen Etex moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Theragen Etex CoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Theragen Etex can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Theragen Stock

Theragen Etex financial ratios help investors to determine whether Theragen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Theragen with respect to the benefits of owning Theragen Etex security.